Focusing on broad industry efforts since 1995, over 1,200 international research scientists have attended Strategic Research Institute's Inflammation & Immune Diseases series - an area that will review emerging drugs with significant market potential.

This year's conference program progresses through two full days of unique scientific presentations, the first day as a general plenary, with the second day tracked into a) inflammatory and b) immune diseases which will address key issues and complexity in finding new treatments.

The Inflammation & Immune Diseases World Summit is the largest meeting of its kind and has been organized to bring together the entire community of immunology & inflammatory researchers for the first time, as they will review many of their programs intended to generate next generation drugs.

KEYNOTE PRESENTATIONS:

Anti-Cytokine Therapies for Treating Human Disease
Charles A. Dinarello, M.D.
Professor of Medicine
UNIVERSITY OF COLORADO HEALTH SCIENCE CENTER

Corticosteroids - The Next Generation
Stuart Farrow, Ph.D.
Section Head, Asthma Biology, Respiratory and Inflammation Centre of Excellence
GLAXOSMITHKLINE

Role of B Cells in Autoimmune Diseases
Peter E. Lipsky, M.D.
Director, Intramural Research Program - Arthritis, Musculoskeletal & Skin Diseases
NATIONAL INSTITUTES OF HEALTH (NIH)

SCIENTIFIC ADVISORY BOARD:

Alan Lewis, Ph.D.
CEO
CELGENE SAN DIEGO

Brett Monia, Ph.D.
Vice President, Antisense Discovery
ISIS PHARMACEUTICALS

Martin Braddock, Ph.D.
Associate Director, Respiratory & Inflammation Research Area
ASTRAZENECA UK

James G. Karras, Ph.D.
Associate Director, Antisense Drug Discovery
ISIS PHARMACEUTICALS

Alvin F. Wells, M.D., Ph.D.
Director, Rheumatology
LAKESHORE MEDICAL CLINIC

PRESENTING COMPANIES:

3M Pharmaceuticals
Abbott Bioresearch Center
Amgen, Inc. - San Francisco (Formerly Tularik)
Amgen, Inc. - Seattle (Formerly Immunex)
AstraZeneca
AstraZeneca R&D Charnwood, UK
Biovation Ltd., UK
Celgene Corporation
Celgene San Diego
Galapagos Genomics
GlaxoSmithKline
Incyte Corporation
Isis Pharmaceuticals
MD Biosciences
Merck Research Laboratories
Millennium Pharmaceuticals
Novartis Pharmaceuticals
Pfizer Global Research & Development
Protein Design Labs
Rigel, Inc.
Sangamo Biosciences
Sanofi Aventis
Vertex Pharmaceuticals
Wyeth Discovery Research
Lakeshore Medical Clinic
National Institutes of Health (NIH)
The Rayne Institute
University of Colorado Health Science Center
University of Glasgow
University of Sheffield, UK